244 related articles for article (PubMed ID: 6158885)
1. [Aprotinin-ACD-blood: I. Experimental studies on the effect of aprotinin on the plasmatic and thrombocytic coagulation (author's transl)].
Harke H; Gennrich M
Anaesthesist; 1980 May; 29(5):266-76. PubMed ID: 6158885
[TBL] [Abstract][Full Text] [Related]
2. [Effect of acetylsalicylic acid and aprotinin on the platelet function and coagulation of preserved blood].
Haas-Denk S; Kaunzner W; von Sommoggy S
Med Welt; 1977 May; 28(19):912-4. PubMed ID: 301977
[No Abstract] [Full Text] [Related]
3. [Aprotinin-ACD-blood. II. The effect of aprotinin on the release of cellular mediators and enzymes in banked blood (author's transl)].
Harke H; Stienen G; Rahman S; Flohr H
Anaesthesist; 1982 Apr; 31(4):165-71. PubMed ID: 6178308
[TBL] [Abstract][Full Text] [Related]
4. Effects of alpha-tocopherol on platelets and the coagulation system.
Bakaltcheva I; Gyimah D; Reid T
Platelets; 2001 Nov; 12(7):389-94. PubMed ID: 11674855
[TBL] [Abstract][Full Text] [Related]
5. Influence of cytotoxic drugs on platelet functions and coagulation in vitro. IV. Melphalan.
Klener P; Kubisz P; Suranová J
Thromb Haemost; 1977 Feb; 37(1):53-61. PubMed ID: 576517
[TBL] [Abstract][Full Text] [Related]
6. [Prevention of microaggregation in stored blood (author's transl)].
Harke H
Anaesthesist; 1976 Aug; 25(8):374-9. PubMed ID: 1085108
[TBL] [Abstract][Full Text] [Related]
7. [Oral anticoagulants and platelet function in hypolipemic therapy using a new clofibrate analog (BM 15.075) (author's transl)].
Zimmermann R; Hoffrichter A; Walter E; Ehlers W; Andrassy K; Lang PD; Schlierf G; Weber E; Barth P
Dtsch Med Wochenschr; 1977 Apr; 102(14):509-12. PubMed ID: 852404
[TBL] [Abstract][Full Text] [Related]
8. [Experimental analysis of the antifibrinolytic, antiplasmin and anti-platelet aggregation activity of aprotinin ].
Imperatore A; Alfano C; Somma AA; Vairo G; De Felice D; Pedone P
Arch Sci Med (Torino); 1978; 135(2):219-32. PubMed ID: 308361
[No Abstract] [Full Text] [Related]
9. Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion.
Wachtfogel YT; Kucich U; Hack CE; Gluszko P; Niewiarowski S; Colman RW; Edmunds LH
J Thorac Cardiovasc Surg; 1993 Jul; 106(1):1-9; discussion 9-10. PubMed ID: 7686593
[TBL] [Abstract][Full Text] [Related]
10. The effects of aprotinin on platelet function in blood exposed to eptifibatide: an in vitro analysis.
Schmer RG; Stammers AH; Ahlgren RL; Ellis TA; Gao C; Nutter BT; Holcomb HB; Hock LM
J Extra Corpor Technol; 2003 Dec; 35(4):304-11. PubMed ID: 14979421
[TBL] [Abstract][Full Text] [Related]
11. Human platelet acetylcholinesterase: the effects of anticholinesterases on platelet function.
Smith MJ; Braem B; Davis KD
Thromb Haemost; 1980 Feb; 42(5):1615-9. PubMed ID: 7368161
[TBL] [Abstract][Full Text] [Related]
12. [Effects of thrombolysis on platelets and coagulation].
Helft G; Abdelouahed M; Vacheron A; Lecompte T; Samama MM
Ann Cardiol Angeiol (Paris); 1995 Sep; 44(7):354-60. PubMed ID: 8561440
[TBL] [Abstract][Full Text] [Related]
13. Cold temperatures reduce the sensitivity of stored platelets to disaggregating agents.
Mondoro TH; Vostal JG
Platelets; 2002 Feb; 13(1):11-20. PubMed ID: 11918832
[TBL] [Abstract][Full Text] [Related]
14. Reduction of heparin binding to and inhibition of platelets by aprotinin.
John LC; Rees GM; Kovacs IB
Ann Thorac Surg; 1993 May; 55(5):1175-9. PubMed ID: 7684217
[TBL] [Abstract][Full Text] [Related]
15. The influence of intrinsic coagulation pathway on blood platelets activation by oxidized cellulose.
Krízová P; Másová L; Suttnar J; Salaj P; Dyr JE; Homola J; Pecka M
J Biomed Mater Res A; 2007 Aug; 82(2):274-80. PubMed ID: 17274026
[TBL] [Abstract][Full Text] [Related]
16. Effects of aprotinin in platelet aggregation and cytosolic free calcium in swine platelets.
Huang C; Qin YM; Liang NC
Zhongguo Yao Li Xue Bao; 1993 Nov; 14(6):565-7. PubMed ID: 7516610
[TBL] [Abstract][Full Text] [Related]
17. [Effect of heparin and ASA on changes of haemostasis induced by venous occlusion (author's transl)].
Vinazzer H; Loew D
Blut; 1978 May; 36(5):275-83. PubMed ID: 656635
[TBL] [Abstract][Full Text] [Related]
18. Aprotinin, an antifibrinolytic drug, attenuates bradykinin-induced permeability in conscious rats via platelets and neutrophils.
O'Brien JG; Battistini B; Farmer P; Johnson RJ; Zaharia F; Plante GE; Sirois P
Can J Physiol Pharmacol; 1997 Jun; 75(6):741-9. PubMed ID: 9276158
[TBL] [Abstract][Full Text] [Related]
19. Characterization of plasmin-induced platelet aggregation.
Watabe A; Ohta M; Matsuyama N; Mizuno K; el Borai N; Tanimoto T; Kawanishi T; Hayakawa T
Res Commun Mol Pathol Pharmacol; 1997 Jun; 96(3):341-52. PubMed ID: 9261893
[TBL] [Abstract][Full Text] [Related]
20. [Potassium, magnesium, copper, manganese and cobalt salts of aspartic acid on platelet factor 3 availability (author's transl)].
Reuter HD; Schröter G
Arzneimittelforschung; 1980; 30(12):2106-8. PubMed ID: 7194069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
